ArticleInternational dental journal2026
proBDNF-SorCS2 Axis Suppresses Osteogenesis and Augments Inflammation of Human Periodontal Ligament Stem Cells in Inflammatory Conditions.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesPeriodontitis is a chronic inflammatory disease occurring in periodontal supporting tissues. Periodontal ligament stem cells (PDLSCs) are considered a promising source for periodontal regeneration and periodontitis treatment. Previous studies have shown that mature brain-derived neurotrophic factor (BDNF) can promote the multidirectional differentiation potential of PDLSCs. It has also been found that the proBDNF (precursor form of BDNF)-mediated signaling pathway is involved in immune-inflammatory diseases. In addition, some scholars have found that proBDNF and its receptor, sortilin-related central nervous system expressed receptor 2 (SorSC2), can induce cell apoptosis. However, the role of the proBDNF-SorCS2 axis in the development of periodontitis and its influence on human periodontal ligament stem cells (hPDLSCs) has not been elucidated. Our present experiment aims to investigate the relationship between the proBDNF-SorCS2 axis and periodontitis, as well as the role of proBDNF-SorCS2 in the osteogenic differentiation of hPDLSCs.
methodsIn this study, 30 patients with periodontitis (PD) and 30 healthy controls (Cont) were selected to detect the protein expression level and the distribution of the proBDNF-SorCS2 axis in periodontal tissues. In addition, an inflammatory model of hPDLSCs was established to study the regulation of SorCS2 expression on inflammation and cell osteoblastic differentiation.
resultsIn our experimental results, we found that the protein expressions of proBDNF and receptor SorCS2 were significantly increased in periodontitis tissues and colocalized with the hPDLSC surface marker CD90. Importantly, we found that the reduction of SorCS2 in hPDLSCs inhibited the protein activity of the proBDNF-SorCS2 signaling axis, IL-6, and IL-1β, promoting osteogenic differentiation of hPDLSCs. We also note that the proBDNF-SorCS2 signaling axis is involved in the activation of the JNK signaling pathway.
conclusionThe protein levels of both proBDNF and its receptor SorCS2 were significantly upregulated in periodontitis tissues and involved in regulating the inflammatory expression level and osteogenic differentiation of hPDLSCs. The proBDNF-SorCS2 axis represents a promising target for novel, localized therapeutic interventions in periodontitis. CLINICAL RELEVANCE: The current study provides a new theoretical perspective and information for the treatment of periodontitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.